October
Cell & Gene Therapy
Strategy Meeting Europe 2023
Innovative Manufacturing, Clinical & Logistical Strategies to Boost Cell & Gene Therapy Efficacy and Accessibility to Patients
What makes our strategy meetings unique?
Roundtable Discussions
Intimate discussions led by renowned industry experts. Have your voice heard and debate alongside like-minded life science executives.
Unrivalled Networking
With senior delegation from big pharma and innovative biotech from across Europe, you can network with peers from different locations, all in one place.
Personalised Agenda
Choose the topics that matter to you. Reserve your place at the roundtable discussions and ensure your whole day delivers the insights you need to hear.
Solutions to your Problems
We’ve partnered with the best solution providers to solve your biggest challenges. Engage in pre-arranged, private meetings to address your specific needs and find a tangible solution.
Industry Researched Topics
We guarantee our agenda is up-to-date and mission critical because its designed by you. We speak to our extended network of senior decision makers to ensure the most important topics are discussed.
Senior Decision Makers
The entire strategy meeting is specifically tailored to the needs and challenges of senior life science professionals. Discover how your peers are dealing with the same challenges as you.
Meet Our Past Facilitators
Our panel of facilitators play a key role in shaping the agenda for the day. See who will be bringing their expertise to the table at our Cell & Gene Therapy Meeting.
Allan Van Konynenburg
Senior Director, Global Depot Network SanaClisFeliks Kochan
Account Executive Business Development Manager Peli BiothermalEduard Ayuso
Chief Technical Officer DinaquorGiner Bjoern
MS&T Technical Steward Cell and Gene Therapy NovartisIvan Gorbachov
Senior Director Novartis Gene TherapiesAmir Goudarzi
Senior Director, Bioprocessing Technologies BayerEric Halioua
Chief Executive Officer & President PDC*Line PharmaSteen Klysner
CEO Amarna TherapeuticsDorothea Ledergerber
Chief Technical Officer Tigen PharmaI-Mei Yu
Principle Scientist, RNA & Gene Therapy | Drug Discovery | Precision Therapy Novo NordiskMichael Zaiac
Head of Medical Affairs Oncology Region Europe NovartisWho Should Attend the Event?
Chief Executive Officers
Chief Medical Officer
Chief Scientific Officer
Senior Vice Presidents
Vice Presidents
Executive Directors
Global Heads
Directors
Executive Director
Responsible For:
Cell Therapy
Cell Engineering
Biotherapeutics
Regenerative Medicine
Immune Deficiencies
CART
Cellular Immunotherapy
Supply Chain
Manufacturing
AAV
Lentivectors
TCR Cell Immunotherapies
mRNA/DNA
CRISPR/CAS
See Which Topics Are Discussed at the Strategy Meeting
Roundtable Tracks
1Roundtable Tracks
2Reasons To Attend the Strategy Meeting
Explore the future of cell-based immunotherapy: autologous vs allogeneicrntreatment
Novel insights into the new class of CAR T-cells on the horizon that can target previously untargetable cancer drivers
Investigate strategies on how to overcome AAV innate immunity barriers tornfurther gene therapy development
Discuss key considerations when designing clinical trials for rare diseases inrngene therapy
Press play to hear what your colleagues had to say...
Become an official strategy meeting partner
Whatever your business needs, we can help. Get in touch for partnering opportunitiesHere To Help
Want to know more? Interested in sponsoring the event? Need help registering your team?rnrnJust get in touch and a member of the team will be happy to help.